Browse > Article
http://dx.doi.org/10.15324/kjcls.2020.52.2.119

Association between Pulse Pressure and Impaired Pulmonary Function in Non-Smoking Adults  

Yoon, Hyun (Department of Clinical Laboratory Science, Wonkwang Health Science University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.52, no.2, 2020 , pp. 119-127 More about this Journal
Abstract
According to previous studies, an impaired pulmonary function is associated with arterial stiffness (AS). The pulse pressure (PP) is an important predictor of AS, but the association of an impaired pulmonary function with the PP is unclear. Therefore, this study assessed the associations between the PP and the predicted forced vital capacity (predicted FVC) and predicted forced expiratory volume in one second (predicted FEV1) in Korean non-smoking adults. The data obtained from 6,857 adults during the 2013~2015 Korean National Health and Nutrition Examination Survey were analyzed. After adjusting for the related variables, the ORs of restrictive pulmonary disease (RPD, the predicted FVC<80.0% with FEV1/FVC≥70.0%) using the normal PP group (PP≤60 mmHg) as a reference group was significant for the high PP group (PP>60 mmHg; 1.337 [95% confidence interval (CI), 1.049~1.703]). In addition, the ORs of obstructive pulmonary disease (OPD, FEV1/FVC<70.0%) using the normal PP group as a reference group were significant for the high PP group (1.339 [95% CI, 1.093~1.642]). In conclusion, a high PP is positively associated with both RPD and OPD in Korean non-smoking adults.
Keywords
Non-smoker; Obstructive pulmonary diseases; Pulse pressure; Restrictive pulmonary diseases;
Citations & Related Records
연도 인용수 순위
  • Reference
1 WHO. Disease burden and mortality estimates 2000-2016 [Internet]. Geneva: WHO; 2017 [cited 2020 May 08]. Available from: https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html
2 Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the renfrew and paisley prospective population study. BMJ. 1996;313:711-715. https://doi.org/10.1136/bmj.313.7059.711   DOI
3 Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127: 1952-1959. https://doi.org/10.1378/chest.127.6.1952   DOI
4 Yokomichi H, Nagai A, Hirata M, Kiyohara Y, Muto K, Ninomiya T, et al. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort. J Epidemiol. 2017;27(3S):98-106. https://doi.org/10.1016/j.je.2016.12.012   DOI
5 Imaizumi Y, Eguchi K, Kario K. Lung disease and hypertension. Pulse. 2014;2:103-112. https://doi.org/10.1159/000381684
6 Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol. 2010;55:1032-1037. https://doi.org/10.1016/j.jacc.2009.09.061   DOI
7 McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;76:1208-1214. https://doi.org/10.1164/rccm.200707-1080OC
8 Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax. 2008;63:306-311. https://doi.org/10.1136/thx.2007.083493   DOI
9 Costanzo L, Pedone C, Battistoni F, Chiurco D, Santangelo S, Antonelli-Incalzi R. Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease. Aging Clin Exp Res. 2017;29:157-164. https://doi.org/10.1007/s40520-016-0560-3   DOI
10 Zhao L, Song Y, Dong P, Li Z, Yang X, Wang S. Brachial pulse pressure and cardiovascular or all-cause mortality in the general population: a meta-analysis of prospective observational studies. J Clin Hypertens. 2014;16:678-685. https://doi.org/10.1111/jch.12375   DOI
11 Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2:8-11. https://doi.org/10.1513/pats.200404-032MS   DOI
12 Dart AM, Kingwell BA. Pulse pressure-a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37:975-984. https://doi.org/10.1016/s0735-1097(01)01108-1   DOI
13 Zheng X, Jin C, Liu Y, Zhang J, Zhu Y, Kan S, et al. Arterial stiffness as a predictor of clinical hypertension. J Clin Hypertens. 2015;17:582-591. https://doi.org/10.1111/jch.12556   DOI
14 Park SY, Oh HJ, Yoon H. Association of metabolic syndrome, metabolic syndrome score and pulse pressure in Korean adults: Korea National Health and Nutrition Survey, 2012. J Korea Acad Industr Coop Soc. 2014;15:5660-5667. http://doi.org/10.5762/KAIS.2014.15.9.5660   DOI
15 Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63:1046-1051. https://doi.org/10.1136/thx.2008.098483   DOI
16 Ranu H, Wilde M, Madden B. Pulmonary function tests. Ulster Med J. 2011;80:84-90. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229853/
17 Tozawa M, Iseki K, Iseki C, Takishita S. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int. 2002;61:717-726. https://doi.org/10.1046/j.1523-1755.2002.00173.x   DOI
18 Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J, Svendsen K, et al. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 2002;287:2677-2683. https://doi.org/10.1001/jama.287.20.2677   DOI
19 Korhonen P, Kautiainen H, Aarnio P. Pulse pressure and subclinical peripheral artery disease. J Hum Hypertens. 2014;28: 242-245. https://doi.org/10.1038/jhh.2013.99   DOI
20 Assmann G, Cullen P, Evers T, Petzinna D, Schulte H. Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. Eur Heart J. 2005;26:2120-2126. https://doi.org/10.1093/eurheartj/ehi467   DOI
21 Chrysant GS. Peripheral vascular disease is associated with increased pulse wave velocity and augmentation index: clinical implications. J Clin Hypertens. 2014;16:788-789. https://doi.org/10.1111/jch.12407   DOI
22 Nitta K, Akiba T, Uchida K, Otsubo S, Otsubo Y, Takei T, et al. Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res. 2004;27:47-52. https://doi.org/10.1291/hypres.27.47   DOI
23 Brahimi M, Dahan M, Dabiré H, Levy BI. Impact of pulse pressure on degree of cardiac hypertrophy in patients with chronic uraemia. J Hypertens. 2000;18:1645-1650. https://doi.org/10.1097/00004872-200018110-00016   DOI
24 Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491-2501. https://doi.org/10.1161/CIRCULATIONAHA.110.011031   DOI
25 Palmieri V, Devereux RB, Hollywood J, Bella JN, Liu JE, Lee ET, et al. Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the strong heart study. Am J Hypertens. 2006;19:601-607. https://doi.org/10.1016/j.amjhyper.2005.12.009   DOI
26 Toprak A, Reddy J, Chen W, Srinivasan S, Berenson G. Relation of pulse pressure and arterial stiffness to concentric left ventricular hypertrophy in young men (from the Bogalusa Heart Study). Am J Cardiol. 2009;103:978-984. https://doi.org/10.1016/j.amjcard. 2008.12.011   DOI
27 Vaccarino V, Holford TR, Krumholz HM. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol. 2000;36:130-138. https://doi.org/10.1016/s0735-1097(00)00687-2   DOI
28 Haider AW, Larson MG, Franklin SS, Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2003;138:10-16. https://doi.org/10.7326/0003-4819-138-1-200301070-00006   DOI
29 Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107:2864-2869. https://doi.org/10.1161/01.CIR.0000069826.36125.B4   DOI
30 Kaushal M, Shah PS, Shah AD, Francis SA, Patel NV, Kothari KK. Chronic obstructive pulmonary disease and cardiac comorbidities: a cross-sectional study. Lung India. 2016;33:404-409. https://doi.org/10.4103/0970-2113.184874   DOI
31 Pelà G, Li Calzi M, Pinelli S, Andreoli R, Sverzellati N, Bertorelli G, et al. Left ventricular structure and remodeling in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1015-1022. https://doi.org/10.2147/COPD.S102831
32 Olson TP, Beck KC, Johnson BD. Pulmonary function changes associated with cardiomegaly in chronic heart failure. J Card Fail. 2007;13:100-107. https://doi.org/10.1016/j.cardfail.2006.10.018   DOI
33 Kolb TM, Hassoun PM. Right ventricular dysfunction in chronic lung disease. Cardiol Clin. 2012;30:243-256. https://doi.org/10.1016/j.ccl.2012.03.005   DOI
34 Zureik M, Benetos A, Neukirch C, Courbon D, Bean K, Thomas F, et al. Reduced pulmonary function is associated with central arterial stiffness in men. Am J Respir Crit Care Med. 2001; 164:2181-2185. https://doi.org/10.1164/ajrccm.164.12.2107137   DOI
35 Guntheroth WG. Increased pulse pressure causes vascular injury in pulmonary and systemic arteries. Decreasing the pulsatility with banding and vasodilators can stabilize pulmonary hypertension. J Clinic Experiment Cardiol. 2010;1:107. https://doi.org/10.4172/2155-9880.1000107
36 Tan W, Madhavan K, Hunter KS, Park D, Stenmark KR. Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series). Pulm Circ. 2014;4:560-580. https://doi.org/10.1086/677370   DOI
37 Jankowich MD, Taveira T, Wu WC. Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: data from NHANES III. Am J Hypertens. 2010;23:614-619. https://doi.org/10.1038/ajh.2010.37   DOI
38 Peled N, Shitrit D, Fox BD, Shlomi D, Amital A, Bendayan D, et al. Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension. J Rheumatol. 2009;36:970-975. https://doi.org/10.3899/jrheum.081088   DOI
39 Nettleton JA, Follis JL, Schabath MB. Coffee intake, smoking, and pulmonary function in the atherosclerosis risk in communities study. Am J Epidemiol. 2009;169:1445-1453. https://doi.org/10.1093/aje/kwp068   DOI
40 Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003;41:183-187. https://doi.org/10.1161/01.hyp.0000047464.66901.60   DOI